Hunan Warrant PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Hunan Warrant PharmaceuticalLtd has a total shareholder equity of CN¥1.8B and total debt of CN¥46.9M, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are CN¥2.3B and CN¥445.5M respectively. Hunan Warrant PharmaceuticalLtd's EBIT is CN¥220.7M making its interest coverage ratio -14.7. It has cash and short-term investments of CN¥461.5M.
Key information
2.6%
Debt to equity ratio
CN¥46.95m
Debt
Interest coverage ratio | -14.7x |
Cash | CN¥461.51m |
Equity | CN¥1.82b |
Total liabilities | CN¥445.53m |
Total assets | CN¥2.27b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688799's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥344.9M).
Long Term Liabilities: 688799's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥100.6M).
Debt to Equity History and Analysis
Debt Level: 688799 has more cash than its total debt.
Reducing Debt: 688799's debt to equity ratio has increased from 0.08% to 2.6% over the past 5 years.
Debt Coverage: 688799's debt is well covered by operating cash flow (439.9%).
Interest Coverage: 688799 earns more interest than it pays, so coverage of interest payments is not a concern.